2022
SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021
Tran TN, Wikle NB, Yang F, Inam H, Leighow S, Gentilesco B, Chan P, Albert E, Strong ER, Pritchard JR, Hanage WP, Hanks EM, Crawford FW, Boni MF. SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021. JAMA Network Open 2022, 5: e2214171. PMID: 35616938, PMCID: PMC9136627, DOI: 10.1001/jamanetworkopen.2022.14171.Peer-Reviewed Original ResearchConceptsHigh vaccine coveragePopulation immunityPublic health agenciesVaccine coverageVaccination campaignMAIN OUTCOMECOVID-19 positive test resultsSARS-CoV-2 attack ratesIntensive care unit occupancyHealth agenciesLarge epidemic waveProportion of vaccinesAttack rateObservational case seriesPopulation-level immunitySARS-CoV-2Median ageCase seriesCOVID-19 casesPercentage of individualsVaccination planningDelta variantOngoing epidemicPandemic settingVaccine
2019
Divergent estimates of HIV incidence among people who inject drugs in Ukraine
Morozova O, Booth RE, Dvoriak S, Dumchev K, Sazonova Y, Saliuk T, Crawford FW. Divergent estimates of HIV incidence among people who inject drugs in Ukraine. International Journal Of Drug Policy 2019, 73: 156-162. PMID: 31405731, PMCID: PMC6899203, DOI: 10.1016/j.drugpo.2019.07.023.Peer-Reviewed Original ResearchConceptsHIV incidenceStudy subjectsBio-behavioral surveillance surveysRecent syringe sharingPopulation of PWIDLongitudinal cohort studyDrug of choiceLow-risk individualsCross-sectional surveyBaseline characteristicsCohort studyAverage monthly numberRisk stratificationSyringe sharingIntervention trialsSurveillance SurveyHigh incidenceRisk individualsRCTsPWIDStudy designIncidenceDrugsFuture surveillanceSignificant differences
2018
Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011–15: a modelling study
Gonsalves GS, Crawford FW. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011–15: a modelling study. The Lancet HIV 2018, 5: e569-e577. PMID: 30220531, PMCID: PMC6192548, DOI: 10.1016/s2352-3018(18)30176-0.Peer-Reviewed Original ResearchConceptsUndiagnosed HIV infectionHIV infectionUS National InstitutesHIV outbreakPublic health responseCase-finding rateNumber of infectionsNational InstituteHealth responseCumulative HIV incidenceHIV transmission ratesEarly public health responsesHarm reduction interventionsScott CountyPublic health emergencyHIV testingHIV incidenceHIV servicesUS CentersNascent epidemicsPrevention servicesInfectionDisease controlSame interventionDrug abuse
2017
The burden of typhoid fever in low- and middle-income countries: A meta-regression approach
Antillón M, Warren JL, Crawford FW, Weinberger DM, Kürüm E, Pak GD, Marks F, Pitzer VE. The burden of typhoid fever in low- and middle-income countries: A meta-regression approach. PLOS Neglected Tropical Diseases 2017, 11: e0005376. PMID: 28241011, PMCID: PMC5344533, DOI: 10.1371/journal.pntd.0005376.Peer-Reviewed Original Research
2016
Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic
Kunkel A, Crawford FW, Shepherd J, Cohen T. Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic. AIDS 2016, 30: 2715-2723. PMID: 27782966, PMCID: PMC5089846, DOI: 10.1097/qad.0000000000001235.Peer-Reviewed Original ResearchConceptsContinuous isoniazid preventive therapyIsoniazid preventive therapyIsoniazid-resistant tuberculosisTB epidemicPreventive therapyEffective TB treatmentLatent TB infectionTB drug resistanceTransmission dynamic modelTB infectionMortality benefitTB treatmentHIV controlHIV incidenceTB incidenceTB transmissionCase findingDrug resistanceIncidenceTuberculosisInitial benefitPLHIVHIVTherapyEpidemic